Compounds > n-n-propyl-n-n-butyl-beta-dopamine
Page last updated: 2024-09-04

n-n-propyl-n-n-butyl-beta-dopamine and levodopa

n-n-propyl-n-n-butyl-beta-dopamine has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(n-n-propyl-n-n-butyl-beta-dopamine)		Trials
(n-n-propyl-n-n-butyl-beta-dopamine)		Recent Studies (post-2010)
(n-n-propyl-n-n-butyl-beta-dopamine)		Studies
(levodopa)		Trials
(levodopa)		Recent Studies (post-2010) (levodopa)
171017,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomyn-n-propyl-n-n-butyl-beta-dopamine (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carey, RA; Jacob, L1

Reviews

1 review(s) available for n-n-propyl-n-n-butyl-beta-dopamine and levodopa

ArticleYear
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:3

    Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine

1989